Abstract. MAMLD1 (mastermind-like domain containing 1), previously known as CXorf6 (chromosome X open reading frame 6), has been shown to be a causative gene for hypospadias. This is primarily based on the identification of nonsense mutations (E124X, Q197X, and R653X), which undergo nonsense mediated mRNA decay, in patients with penoscrotal hypospadias. Subsequent molecular studies have shown that the mouse homolog is transiently expressed in fetal Sertoli and Leydig cells around the critical period for sex development, and that transient knockdown of Mamld1 results in significantly reduced testosterone production in murine Leydig tumor cells. These findings suggest that the MAMLD1 mutations cause hypospadias primarily because of compromised testosterone production around the critical period for sex development.
Introduction
Hypospadias is defined by the urethral opening on the ventral side of the penis, and is classified into mild glandular or penile type and severe penoscrotal or perineal type (1) . It is a mild form of 46,XY disorders of sex development (DSD), and affects approximately 0.5% of male newborns (2) . Hypospadias is primarily caused by compromised androgen effects, and appears as an isolated anomaly or in association with other genital anomalies such as micropenis and cryptorchidism. To date, while mutation analyses have been performed for multiple genes involved in androgen effects such as SRD5A2 for 5-alpharedeuctase and AR for androgen receptor, pathologic mutations have been identified in only a very small portion of patients (2) . This would be consistent with hypospadias being a highly heterogeneous condition subject to multiple genetic and environmental factors.
We have recently shown that CXorf6 (chromosome X open reading frame 6) is a novel gene for hypospadias (3) , and coined a new gene symbol MAMLD1 (mastermind-like domain containing, 1) on the basis of its characteristic protein structure with homology to mastermind like 2 (MAML2) protein (4) . Herein, we review the current knowledge about MAMLD1.
Cloning of a Candidate Gene for 46,XY DSD
A gene for 46,XY DSD has been postulated around MTM1 for myotubular myopathy on Xq28, on the basis of the finding that genital development was normal in patients with intragenic MTM1 mutations, and invariably abnormal in six patients Vol.17 / No.4 with microdeletions involving MTM1 (5) (6) (7) (8) . The six patients consisted of three sporadic and three familial cases, and fi ve of them have glandular, penile, or penoscrotal hypospadias; the remaining one exhibits ambiguous genitalia (5-7). These fi ndings suggest that a gene for 46,XY DSD, especially that for hypospadias, resides in the vicinity of MTM1, and that loss or disruption of the gene results in the development of 46,XY DSD as consequence of contiguous gene deletion syndrome.
In 1997, Laporte et al. (9) identifi ed MAMLD1 from a 430-kb region deleted in two sporadic cases with myotubular myopathy and 46,XY DSD (7) . MAMLD1 comprises at least seven exons, and harbors an open reading frame on exons 3-6 that is predicted to produce two proteins of 701 and 660 amino acids as a result of in-frame alternative splicing with and without exon 4. Furthermore, subsequent studies have shown loss of MAMLD1 in all patients with myotubular myopathy and 46,XY DSD (our unpublished observation), and no other candidate gene for 46,XY DSD has been identifi ed within the commonly deleted region. These fi ndings imply that MAMLD1 is an excellent candidate gene for 46,XY DSD, especially hypospadias.
MAMLD1 Mutations in Hypospadiac Patients
We performed direct sequencing for the coding exons 3-6 and their fl anking splice sites of MAMLD1 in 166 patients including 56 cases with hypospadias. Consequently, three nonsense mutations were identifi ed in Japanese patients with hypospadias: E124X in maternally related half brothers from family A (cases 1 and 2), Q197X in a patient from family B (case 3), and R653X in a patient from family C (case 4) ( Fig. 1 ) (3). The mothers of families A and C were heterozygous for the mutations, although the mother of family B was not studied.
Nonsense Mediated mRNA Decay (NMD)
One may argue that the hypospadias in case 4 with R653X on exon 5 is inconsistent with the apparently normal genital development in a previously reported boy with a microdeletion involving MTM1 that has resulted in generation of a fusion gene between exons 1-4 of CXorf6 and exons 3-16 of MTMR1 (locus order: CXorf6-MTM1-MTMR1), because the coding exons 3 and 4 are preserved in both case 4 and the boy with the fusion gene (10) (Fig. 2) . However, in contrast to the positive expression of the fusion gene confi rmed in the biopsied muscle tissue (10), the three nonsense mutations are predicted to cause NMD because of their positions (11) . Consistent with this, RT-PCR for leukocytes indicated drastically reduced transcripts in cases 1-4 (Fig.  3) . Furthermore, NMD was protected by an NMD inhibitor cycloheximide, providing further support for the occurrence of NMD in the three nonsense mutations (3, 4) . Thus, although NMD has not been confi rmed in the testicular tissue, the results explain the apparent discordance in the genital development between case 4 and the boy described by Tsai et al. (10) , and indicate that the three nonsense mutations including R653X are pathologic mutations. 
Phenotypes in Mutation Positive Patients
Cases 1-4 had penoscrotal hypospadias with chordee as the conspicuous genital phenotype, in association with other genital phenotypes ( Table 1) . Pituitary-gonadal serum hormone values remained within the normal range, including the human chorionic gonadotropin (hCG)-stimulated testosterone value in case 1 at two years and fi ve mo of age, and the basal testosterone values in case 2 at one mo of age and in case 4 at three mo of age when serum testosterone is physiologically elevated. Thus, the diagnosis of idiopathic hypospadias was initially made in cases 1-4. It was suspected that testosterone production was compromised only during fetal life, or that external genitalia had defective development of anlagen or impaired responsiveness to testosterone. While placental dysfunction could also affect male genital development by attenuating the production of hCG (2), there was no pregnant episode suggestive of placental dysfunction.
In situ Hybridization (ISH) Analysis for
Mouse Mamld1 type-specific expression pattern (3) . Namely, Mamld1 is specifically and transiently expressed in Sertoli and Leydig cells around the critical period for sex development (E12.5-E14.5) (Fig.  4) . This expression pattern has been confirmed by double staining with antibodies for Ad4bp/ Sf-1 that serves as a marker for Sertoli and Leydig cells. In extragonadal tissues at E12.5, Mamld1 expression was absent in the adrenals and weakly and diffusely identified in the external genital region including the genital tubercle at a level similar to that detected in the neighboring extragenital tissues (Fig. 2B) .
ISH analysis for mouse
Mamld1 was also clearly expressed in the Müllerian ducts, forebrain, somite, neural tube, and pancreas. By contrast, Mamld1 expression was absent in the postnatal testes. These data imply that nonsense mutations of MAMLD1 cause hypospadias primarily because of transient testicular dysfunction and resultant compromised testosterone production around the critical period for sex development, and explain why postnatal endocrine data were normal in cases 1-4.
Function of Mamld1 in Testosterone Production
We performed knockdown analysis with siRNAs for Mamld1, using mouse Leydig tumor (MLT) cells that retain the capability of testosterone production and the responsiveness to hCG stimulation (4) . When the mRNA level of endogenous Mamld1 was severely reduced in the mouse Leydig tumor cells (25-30%), testosterone production was decreased to 50-60% of the previous level after 48 h of incubation and one h after hCG stimulation. This implies that MAMLD1 is involved in the testosterone biosynthesis. Furthermore, since testosterone production would probably be attenuated rather than abolished in the absence of MAMLD1, this is consistent with the hypospadias phenotype in the affected patients (2) .
Conclusions
MAMLD1 is a causative gene for hypospadias, and possibly other forms of 46,XY DSD. It appears to play a supportive role in the testosterone production around the critical period for sex development. Further studies including knockout mouse experiments will permit to clarify MAMLD1 dependent molecular network involved in testosterone production.
